LOBE SCIENCES LTD (F:6YX0) — Market Cap & Net Worth
Market Cap & Net Worth: LOBE SCIENCES LTD (6YX0)
LOBE SCIENCES LTD (F:6YX0) has a market capitalization of $2.90 Million (€2.48 Million) as of May 4, 2026. Listed on the F stock exchange, this Germany-based company holds position #29252 globally and #2550 in its home market, demonstrating a -5.66% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying LOBE SCIENCES LTD's stock price €0.03 by its total outstanding shares 171560000 (171.56 Million).
LOBE SCIENCES LTD Market Cap History: 2021 to 2025
LOBE SCIENCES LTD's market capitalization history from 2021 to 2025. Data shows change from $3.11 Million to $5.01 Million (-28.35% CAGR).
LOBE SCIENCES LTD Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how LOBE SCIENCES LTD's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of 6YX0 by Market Capitalization
Companies near LOBE SCIENCES LTD in the global market cap rankings as of May 4, 2026.
Key companies related to LOBE SCIENCES LTD by market ranking:
- Vertex Pharmaceuticals Inc (NASDAQ:VRTX): Ranked #223 globally with a market cap of $107.56 Billion USD.
- Regeneron Pharmaceuticals Inc (NASDAQ:REGN): Ranked #367 globally with a market cap of $72.88 Billion USD.
- UCB SA (BR:UCB): Ranked #517 globally with a market cap of $51.45 Billion USD ( €44.01 Billion EUR).
- argenx NV ADR (NASDAQ:ARGX): Ranked #568 globally with a market cap of $45.97 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #223 | Vertex Pharmaceuticals Inc | NASDAQ:VRTX | $107.56 Billion | $423.92 |
| #367 | Regeneron Pharmaceuticals Inc | NASDAQ:REGN | $72.88 Billion | $701.42 |
| #517 | UCB SA | BR:UCB | $51.45 Billion | €231.20 |
| #568 | argenx NV ADR | NASDAQ:ARGX | $45.97 Billion | $787.95 |
LOBE SCIENCES LTD Historical Marketcap From 2021 to 2025
Between 2021 and today, LOBE SCIENCES LTD's market cap moved from $3.11 Million to $ 5.01 Million, with a yearly change of -28.35%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | €5.01 Million | +100.00% |
| 2024 | €2.51 Million | +31.58% |
| 2023 | €1.91 Million | -52.50% |
| 2022 | €4.01 Million | +29.03% |
| 2021 | €3.11 Million | -- |
End of Day Market Cap According to Different Sources
On May 3rd, 2026 the market cap of LOBE SCIENCES LTD was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.90 Million USD |
| MoneyControl | $2.90 Million USD |
| MarketWatch | $2.90 Million USD |
| marketcap.company | $2.90 Million USD |
| Reuters | $2.90 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About LOBE SCIENCES LTD
Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. was founded in 2018 and is headquartered in Vancouv… Read more